Daniel Calabrese
Assoc Professor in Residence · University of California (San Francisco) School of Medicine
Credentials: · · · · · ·
History
- 2007–2011
- 1998–2002
Research
Sepsis promotes splenic production of a protective platelet pool with high CD40 ligand expression
Journal of Clinical Investigation · 2022 · 91 citations
Natural killer cells activated through NKG2D mediate lung ischemia-reperfusion injury
Journal of Clinical Investigation · 2021 · First of 16 authors · 67 citations
Planar relationships of the semicircular canals in two strains of mice
Journal of the Association for Research in Otolaryngology · 2006 · First of 2 authors · 57 citations
57 papers · 2 as a fellow
39 papers
37 papers
31 papers
22 papers
18 papers · 2 as a resident
16 papers · 4 as a resident
15 papers · 1 as a fellow
Grants
- 2026–2031
Adaptive-Like Natural Killer Cells in Pulmonary Cytomegalovirus Reactivation
National Heart, Lung, and Blood Institute · R01
Contact PI · $795.5K · University of California, San Francisco
- 2025–2028
EPIC-LT: Eliminating PGD Through Inhibition of CCR5 in Lung Transplantation
National Heart, Lung, and Blood Institute · R34
Contact PI · $548.6K · University of California, San Francisco
- 2021–2026
Natural Killer Cells in Pulmonary Ischemia-Reperfusion Injury
Department of Veterans Affairs · IK2
Contact PI · Veterans Affairs Med Ctr San Francisco
Clinical trials
- 2025–2028
Principal investigator · Recruiting · Phase 2
University of California, San Francisco